Last reviewed · How we verify
Immunonutrition ( Impact)
Impact is an immunonutrition formula that provides specialized nutrients (arginine, omega-3 fatty acids, and nucleotides) to enhance immune function and reduce inflammatory response in critically ill or post-surgical patients.
Impact is an immunonutrition formula that provides specialized nutrients (arginine, omega-3 fatty acids, and nucleotides) to enhance immune function and reduce inflammatory response in critically ill or post-surgical patients. Used for Nutritional support in critically ill patients, Post-surgical nutritional support, Immune function enhancement in hospitalized patients.
At a glance
| Generic name | Immunonutrition ( Impact) |
|---|---|
| Sponsor | St. Antonius Hospital |
| Drug class | Immunonutrition supplement |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Nutritional Support |
| Phase | FDA-approved |
Mechanism of action
Impact contains a combination of immunomodulating nutrients designed to support immune competence and reduce infection risk in hospitalized patients. The formula includes L-arginine (which supports T-cell function and wound healing), fish oil-derived omega-3 fatty acids (which modulate inflammatory mediators), and RNA nucleotides (which enhance immune cell proliferation). These components work synergistically to optimize nutritional support while promoting a balanced immune response.
Approved indications
- Nutritional support in critically ill patients
- Post-surgical nutritional support
- Immune function enhancement in hospitalized patients
Common side effects
- Gastrointestinal tolerance issues
- Diarrhea
- Nausea
Key clinical trials
- ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study (NA)
- Pre-Surgical Immunonutrition's Effect on Colorectal Surgery (NA)
- Esophageal Cancer Multimodal Prehabilitation Study (NA)
- Phase II Trial of Immunonutrition in Hepatectomy (NA)
- Impact of Various Diets on Surgical Complications (NA)
- GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis (PHASE3)
- The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) (PHASE3)
- The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Immunonutrition ( Impact) CI brief — competitive landscape report
- Immunonutrition ( Impact) updates RSS · CI watch RSS
- St. Antonius Hospital portfolio CI